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Introduction: The use of sputum induction by inhalation of hypertonic saline to study the
cellular and biochemical composition of the airways allows noninvasive sampling of the
airways content and identification of markers of airways inflammation.
Objective: The present study aimed to identify possible changes in the cellular
composition of induced sputum between samples obtained sequentially (three periods of
5min each) during one sputum induction. Moreover, difference between these samples and
the mixed one (mixture of samples obtained after 5, 10 and 15min of induction) was
investigated.
Methods: Forty-six subjects (10 healthy volunteers, 12 patients with chronic obstructive
pulmonary disease (COPD) and 24 patients with asthma) (mean age 53.0714.0 yr, forced
expiratory volume in one second (FEV1) 71.8719.0% pred) produced sputum after three
consecutive 5min periods of hypertonic (4.5%) saline inhalation. Stained cytospins from
the three periods separately and from the mixed sample were produced and analyzed.
Results: The mean percentage of neutrophils, eosinophils, lymphocytes and epithelial
cells did not change significantly in samples obtained consecutively after 5, 10 and 15minElsevier Ltd. All rights reserved.
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of samples obtained after 5, 10 and 15min of induction and the cellular composition of the
mixed sample (P ¼ 0.06).
Conclusion: The separate analysis of induced sputum from three consecutive sampling and
the mixed sample did not demonstrate significant changes in their cellular composition.
Fifteen minutes induction procedure with the fixed concentration of hypertonic saline and
processing of the mixed sample can be recommended for clinical settings and clinical
trials.
& 2007 Elsevier Ltd. All rights reserved.Introduction
The use of sputum induction by inhalation of hypertonic
saline to study the cellular and biochemical composition of
the airways has increased significantly since 1990s. The
induced sputum technique allows sampling of the airways
content in a noninvasive fashion and offers a unique
opportunity to identify biomarkers of potential clinical
utility in respiratory medicine.1 Adequate sample of lower
airway secretions can be collected during the induction
procedure from patients who are not able to produce
sputum spontaneously, and the features of airway inflam-
mation in asthma, chronic obstructive pulmonary disease
(COPD) and other respiratory disorders can be studied. The
method of sputum induction has been demonstrated to be
reproducible, sensitive and valid.2–4
At least three studies have reported the changes of
cellular and biochemical constituents of induced sputum
during the induction procedure.5–7 One of these studies
showed that percentages of neutrophils decreased and
percentages of macrophages increased significantly in the
induced sputum of asthmatics and healthy individuals
obtained during three consecutive inhalation periods of
10min each of one induction procedure.5 The second study
demonstrated pronounced differences in neutrophil counts
in two consecutive samples of sputum derived from healthy
subjects within 30min of one induction procedure.6 How-
ever, in the COPD group, percentages of neutrophils did not
change between the two sputum inductions.6 The third
study collecting sputum samples at 4min intervals during
the 20min induction procedure has also identified significant
changes in the cellular composition.7 In particular, the
percentages of eosinophils and neutrophils decreased, while
the percentages of macrophages increased.
Changes of the cellular composition during the induction
procedure can introduce a bias in clinical settings and in
clinical trials. Moreover, the standardized methodology of
sputum induction and processing states that shorter inhala-
tion times (e.g. 15–20min) appear to have similar success
rates and feasibility to longer inhalation times (30min).8 For
most purposes, the consensus is to use a cumulative duration
of nebulization of 15–20min.8 To the best of our knowledge,
none of the published studies has analyzed possible
significant changes in the cellular composition of different
samples obtained sequentially during 15min of inhalation
procedure. Moreover, not all patients and healthy subjects
are able to produce adequate samples of sputum during the
whole induction procedure. This problem may be solved by
mixing available samples and analyzing the mixed sample.To the best of our knowledge, none of the studies has
evaluated possible changes between consecutive sputum
samples obtained during one induction procedure and the
mixed one.
Thus, the aim of the present study was to identify possible
changes in the cellular composition of induced sputum
between samples obtained sequentially (three periods of
5min each) during one sputum induction. Moreover, differ-
ence between these samples and the mixed one (mixture of




Forty-six subjects (10 healthy volunteers, 12 patients with
moderate COPD and 24 patients with mild to severe asthma)
were selected from already examined group consisting of
individuals who easily produce sputum samples. All subjects
produced easily all three samples of sputum during 15min of
the induction procedure. Demographic and clinical data for
all subjects enrolled in the present study is presented in
Table 1. Healthy subjects were aged-matched; they had no
history of asthma, chronic bronchitis, wheezing or allergies.
The diagnosis of COPD was based on the Global Strategy for
the diagnosis, management and prevention of COPD
(GOLD).9 The diagnosis of asthma was based on Global
Initiative for asthma (GINA).10 Treatment of patients with
asthma and COPD was performed according to GOLD and
GINA standards, respectively.
The protocol was approved by the Local Committee of
Fondazione Salvatore Maugeri and all subjects gave their
informed written consent.
Study design
The subjects visited laboratory during one day. Written
consent was obtained, subjects characteristics were docu-
mented, and spiromentry was performed followed by
inhalation of 200 mg salbutamol and sputum induction for
three consecutive periods of 5min each (totally 15min). The
selected portions of sputum were analyzed.
Sputum induction
After baseline FEV1 and forced vital capacity (FVC)
measurements, subjects inhaled 200 mg salbutamol from a
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Table 1 Demographic and clinical data of 46 subjects enrolled in the study.
Group n Gender M/F Age (yr) FEV1 (% pred) FVC (%)
Healthy 10 1/9 53.3716.5 100.176.8 100.675.3
COPD 12 1/11 53.276.5 53.276.5 79.976.0
Asthma 24 12/12 49.0711.8 69.4711.5 84.677.4
Total 46 14/32 53.0714.0 71.8719.0 86.9710.0
M, male; F, female; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; COPD, chronic obstructive pulmonary
disease.
Data are expressed as mean7SD.
Changes in sputum composition 1545metered dose inhaler. Then, subjects inhaled hypertonic
(4.5%) saline from an ultrasonic nebulizer (DeVilbiss 65,
DeVilbiss Corporation, Somerset, PA, USA)11 for three
consecutive periods of 5min each (totally 15min). FEV1
was measured 1min after each inhalation period to detect
any bronchoconstriction. Severe adverse effects and com-
plications were absent in healthy volunteers and patients.
The sputum samples produced after the first, the second and
the third 5min inhalation periods were processed sepa-
rately. The fourth or the mixed sample was obtained by
mixing together portions of samples derived after 5, 10 and
15min of induction. Sputum samples were examined within
2 h after induction.
Sputum processing
Sputum was collected and processed as previously de-
scribed.11 In brief, selected portions of sputum sample
originating from the lower respiratory tract were chosen
using an inverted microscope and weighed. Dithiothreitol
(DTT) (Sputolysin, Calbiochem Corp, San Diego, CA, USA)
freshly prepared in a dilution of one in 10 with distilled
water, was added to sputum sample. The volume (in ml) of
DTT was equal to four times the weight of the sputum
portion (in mg). The samples of selected sputum were
placed in a shaking water bath at 37 1C for 20min to ensure
complete homogenization. The liquid resulted from selected
portions was further diluted with phosphate buffered saline
(PBS) in a volume equal to the sputum plus DTT. The
suspensions were filtered through nylon gauze to remove
mucus and were centrifuged at 1000 rpm for 5min. The
supernatants were aspirated and frozen at 70 1C for later
analysis. The cell pellets were resuspended in PBS. Total cell
count (TCC) and viability (Trypan blue exclusion method)
were determined using a Burkers chamber haemocytometer.
Cell suspensions were placed in a Shandon 3 cytocentrifuge
(Shandon Southern Instruments, Sewickley, PA, USA) and
cytospins were prepared at 450 rpm for 6min. Cytospin
slides were fixed by methanol and stained by May Grunwald
Giemsa for overall differential cell count on 500 nucleated
nonsquamous cells. Definition of an adequate selected
sputum was one in which there were fewer than 20%
squamous cells and viability 450%.11
Statistical analysis
Descriptive statistics were used to summarize clinical and
demographic characteristic of the subjects. The resultswere expressed as mean and standard deviation for age,
lung function values and cellular composition of induced
sputum. The comparison of differential cell count between
5, 10, 15min and the mixed samples and the comparison of
differential cell count between patients with asthma, COPD
and healthy volunteers were assessed by ANOVA. A value of
Po0.05 was considered statistically significant.Results
The cellular composition of samples obtained after
5, 10 and 15min of induction procedure and the
mixed sample
The weight, TCC and the cellular composition of samples
from 46 subjects (healthy volunteers and patients with
asthma and COPD) obtained after 5, 10 and 15min of one
induction procedure and the mixed sample are presented in
Table 2 and Fig. 1. No statistical difference in TCC and the
mean percentage of neutrophils, eosinophils, lymphocytes
and epithelial cells was observed between samples obtained
after 5, 10 and 15min of induction. The mean percentage of
macrophages was significantly different (Po0.05) in samples
obtained consecutively after 5, 10 and 15min of the
induction procedure. However, there was no significant
difference in the cellular composition of samples obtained
after 5, 10 and 15min of induction and the cellular
composition of the mixed sample (P ¼ 0.06) (Fig. 1). When
analyzing three different groups of subjects (healthy
volunteers and patients with asthma and COPD) separately,
no significant difference was found in the mean percentages
of cells in samples obtained after 5, 10 and 15min of
induction and the mixed sample (P40.05). The significant
increase of macrophages in three samples (5, 10 and 15min)
was characteristic for patients with asthma (Po0.05). When
analyzing the difference in the cellular composition in
absolute numbers, no statistical difference was observed
between samples obtained after 5, 10 and 15min of
induction and between the three samples and the mixed
one (Fig. 1).The cellular composition of induced sputum
obtained from healthy volunteers and patients with
asthma and COPD
Sample obtained 5min after induction from patients with
asthma and COPD were characterized by decreased
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Table 2 Weight and TCC in 5, 10, 15min and the mixed samples obtained from healthy volunteers and patients with asthma
and COPD.
Group Healthy Asthma COPD Total
Weight mg
5min sample 65750 93771 1127100 92776
10min sample 76765 91764 72757 83761
15min sample 91783 76774 58750 75769
Mixed sample 2117167 2527136 2297157 2377146
TCC 106 cellsmL1
5min sample 1.071.2 1.271.4 1.371.2 1.271.3
10min sample 0.871.2 0.871.1 1.271.4 0.971.2
15min sample 0.870.8 0.770.9 1.571.6 0.971.1
Mixed sample 0.870.8 0.971.1 1.371.2 1.071.0
COPD, chronic obstructive pulmonary disease.

































Figure 1 The comparison of differential cell count in
percentages (A) and absolute numbers (B) between 5, 10,
15min and the mixed samples for 46 subjects involved in the
present study; *Po0.05.
O. Toungoussova et al.1546(Po0.05) percentage of macrophages compared with
samples from healthy volunteers (Fig. 2). The percentage
of neutrophils in all samples obtained from patients with
asthma and COPD was increased significantly (Po0.05,Po0.001) in comparison with samples from healthy volun-
teers. The percentage of eosinophils in all samples obtained
from patients with COPD and asthma were significantly
higher (Po0.001) than those in samples from healthy
volunteers.Discussion
According to the aim of our study, we identified changes in
the percentage of macrophages in samples obtained
sequentially (three periods of 5min each) during one
induction procedure. However, the difference in macro-
phages expressed in absolute numbers was not significant.
Moreover, we compared the cellular composition of samples
derived after 5, 10 and 15min of one induction procedure
with the cellular composition of the mixed sample. No
significant changes were identified. In addition, specific
differences of the cellular composition of induced sputum
samples obtained from healthy volunteers and patients with
asthma and COPD were evident. The sputum of patients with
asthma was characterized by eosinophilia. Neutrophilia was
characteristic for sputum obtained from patients with COPD.
Previous studies with long (30min)5,6 and short (20min)7
induction procedure have documented substantial changes
in the cellular composition of induced sputum. In our study,
only the increasing trend of macrophages in 5, 10 and 15min
samples was found significant, which was specifically
characteristic for patients with asthma. Technical factors
including the duration of inhalation procedure, the concen-
tration of saline solution, analysis of entire or selected parts
of sputum and pretreatment with bronchodilator might have
influenced the procedure and the cellular characteristics of
induced sputum. The concentration of saline solution used
for sputum induction was different in all studies. The
concentration of saline in the study of Holz et al.5 was
changed during the procedure, starting with 3% and
subsequently increasing to 4% and 5%, while the concentra-
tion of saline in the study of Richter et al.6 (3%), Gershman
et al.7 (3%) and our study (4.5%) was constant. All patients
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Figure 2 The comparison of differential cell count (A—
macrophages, B—neutrophils and C—eosinophils) between
patients with asthma, COPD and healthy volunteers. COPD:
chronic obstructive pulmonary disease; *Po0.05; **Po0.001.
Changes in sputum composition 1547salbutamol (Holz,5 Ritcher6 and our study) or 360 mg
albuterol (Gershman et al.7 study). It is possible to suggest
that saline concentration and the dose of bronchodilator
might have influenced the procedure and different results.
However, evidence has been provided that different salineconcentrations and pretreatment with bronchodilator do not
affect TCC and differential cell count.12,13 Three of the
studies (Holz et al.,5 Ritcher et al.6 and our study) used
selected plugs of sputum for analysis, while Gershman
et al.7 preferred to analyze the entire expectorate.
Conflicting data exists whether or not differential cell count
differs between the two methods (selected sputum and
entire sputum).14 Thus, using different techniques in sputum
processing and, in addition, different criteria for subject
selection in the studies might have influenced the results.
The originality of our study includes comparison of the
cellular composition of three consecutive samples obtained
during 15min of one inhalation procedure with the cellular
composition of the mixed sample. The cellular composition
of samples obtained after 5, 10 and 15min of induction was
similar to the cellular composition of the mixed sample.
Thus, the mixed sample can represent the real picture of the
induced sputum cellular composition in healthy subjects and
patients with COPD.
Considering absence of significant difference in the
cellular composition between the three samples obtained
during 15min induction procedure, each individual sample
(5, 10 or 15min) can be utilized for analysis. This can be
applied in particular to subjects who are not able to produce
all three adequate sputum samples of secretions from lower
airways during induction. Moreover, the tendency of
increasing of macrophages suggests that the optimal
procedure should include the analysis of the mixed sample
in order to avoid any bias during interpretation of the
results. The analysis of the mixed sample can be also
relevant for the situation when a patient has produced only
two adequate samples of sputum. Current recommendations
of the European Respiratory Society for sputum induction
and processing highlights the need to standardize the
duration of sputum induction.8 Moreover, the standardized
methodology of sputum induction and processing states that
shorter inhalation times (e.g. 15–20min) appear to have
similar success rates and feasibility to longer inhalation
times (30min).8 The duration of the inhalation procedure in
our study was constant (15min), which is in agreement with
the consensus to use cumulative duration of nebulization of
15–20min.8 Thus, 15min induction procedure and proces-
sing of sputum using the mixed sample can be recom-
mended.
The analysis of differential cell count revealed specific
patterns relevant for patients with asthma and COPD. The
percentage of neutrophils is usually increased in sputum of
COPD patients.15 In our study, the neutrophil count in all
samples obtained from COPD patients was significantly
higher than that from healthy volunteers. We observed
significantly increased percentage of eosinophils in all
samples obtained from patients with asthma in comparison
with samples from healthy volunteers and patients with
COPD. All samples from patients with COPD were character-
ized by the significantly higher percentage of eosinophils
than the samples obtained from healthy volunteers. This is
in agreement with already existing knowledge that subjects
with severe acute asthma and up to 40% of subjects with
COPD usually exhibit marked sputum eosinophilia.15
In conclusion, the separate analysis of induced sputum
from three consecutive sampling and the mixed sample did
not demonstrate significant changes in their cellular
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and asthma. Fifteen minutes induction procedure with the
fixed concentration of hypertonic saline and processing of
the mixed sample can be recommended for clinical settings
and clinical trials.
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